These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8629673)

  • 1. A critical pathway to treat proximal lower-extremity deep vein thrombosis.
    Pearson SD; Lee TH; McCabe-Hassan S; Dorsey JL; Goldhaber SZ
    Am J Med; 1996 Mar; 100(3):283-9. PubMed ID: 8629673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway.
    Schoenenberger RA; Pearson SD; Goldhaber SZ; Lee TH
    Am J Med; 1996 Mar; 100(3):278-82. PubMed ID: 8629672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient treatment of deep venous thrombosis: a clinical care pathway managed by the emergency department.
    Vinson DR; Berman DA
    Ann Emerg Med; 2001 Mar; 37(3):251-8. PubMed ID: 11223760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between critical pathway guidelines and management of deep-vein thrombosis: retrospective cohort study.
    Vucić N; Lang N; Balić S; Pilas V; Anić T; Nadinić V; Brborovic O
    Croat Med J; 2000 Jun; 41(2):163-7. PubMed ID: 10853045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical pathway to evaluate suspected deep vein thrombosis.
    Pearson SD; Polak JL; Cartwright S; McCabe-Hassan S; Lee TH; Goldhaber SZ
    Arch Intern Med; 1995 Sep; 155(16):1773-8. PubMed ID: 7654111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pathways--an evaluation of its impact on the quality of care in an acute care general hospital in Singapore.
    Cheah J
    Singapore Med J; 2000 Jul; 41(7):335-46. PubMed ID: 11026801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
    Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS
    Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient treatment of deep vein thrombosis with LMWH.
    Koopman MM
    Wien Med Wochenschr; 1999; 149(2-4):46-9; discussion 49. PubMed ID: 10378322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pathways as a healthcare tool: design, implementation and assessment of a clinical pathway for lower-extremity deep venous thrombosis.
    Verdú A; Maestre A; López P; Gil V; Martín-Hidalgo A; Castaño JA
    Qual Saf Health Care; 2009 Aug; 18(4):314-20. PubMed ID: 19651938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized deep vein thrombosis path allows patient management, not data management.
    Shelton DM
    Hosp Case Manag; 1997 Aug; 5(8):141-4. PubMed ID: 10169511
    [No Abstract]   [Full Text] [Related]  

  • 12. The utility and cost-effectiveness of D-dimer measurements in the diagnosis of deep vein thrombosis.
    Crippa L; D'Angelo SV; Tomassini L; Rizzi B; D'Alessandro G; D'Angelo A
    Haematologica; 1997; 82(4):446-51. PubMed ID: 9299859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute superficial thrombophlebitis--therapeutic strategies].
    Noppeney T; Noppeney J; Winkler M; Kurth I
    Zentralbl Chir; 2006 Feb; 131(1):51-6. PubMed ID: 16485211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and therapy of leg and pelvic deep vein thrombosis in pregnancy].
    Bahlmann F; Hofmann M; Meyer K; Schinzel H; Merz E; Trautmann K
    Zentralbl Gynakol; 2000; 122(7):374-82. PubMed ID: 10951708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin.
    Partsch H; Kechavarz B; Köhn H; Mostbeck A
    Int Angiol; 1997 Sep; 16(3):189-92. PubMed ID: 9405014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making the transition to critical pathways--a community behavioral health center's approach.
    Barnette JE; Clendenen F
    Best Pract Benchmarking Healthc; 1996; 1(3):147-56. PubMed ID: 9192562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF; Matheny SC
    Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the diagnosis and management of deep vein thrombosis.
    Ockelford PA
    N Z Med J; 1984 Aug; 97(761):522-5. PubMed ID: 6591014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.